Literature DB >> 32717423

Heart Failure with Carfilzomib in Patients with Multiple Myeloma: A Meta-analysis of Randomized Controlled Trials.

M Rubayat Rahman1, Somedeb Ball1, Pablo Paz1, Mohamed Elmassry1, Wasawat Vutthikraivit1, Dhrubajyoti Bandyopadhyay2, Carl J Lavie3, Gregg C Fonarow4.   

Abstract

Entities:  

Year:  2020        PMID： 32717423     DOI： 10.1016/j.cardfail.2020.07.006

Source DB:  PubMed          Journal:  J Card Fail        ISSN： 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  3 in total

1.  Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients.

Authors:  Giulia Mingrone; Anna Astarita; Lorenzo Airale; Ilaria Maffei; Marco Cesareo; Teresa Crea; Giulia Bruno; Dario Leone; Eleonora Avenatti; Cinzia Catarinella; Marco Salvini; Giusy Cetani; Francesca Gay; Sara Bringhen; Franco Veglio; Fabrizio Vallelonga; Alberto Milan
Journal:  Front Cardiovasc Med       Date:  2021-04-21

2.  Carfilzomib-induced Cardiotoxicity: An Analysis of the FDA Adverse Event Reporting System (FAERS).

Authors:  Benjamin Buck; Eric Kellett; Daniel Addison; Ajay Vallakati
Journal:  J Saudi Heart Assoc       Date:  2022-08-31

3.  Efficacy and toxicity of carfilzomib- or bortezomib-based regimens for treatment of transplant-ineligible patients with newly diagnosed multiple myeloma: A meta-analysis.

Authors:  Chunhong Xie; Min Wei; Feiyan Yang; Qin Liu; Fuzhen Wu; Jinxiong Huang
Journal:  Medicine (Baltimore)       Date:  2022-09-30       Impact factor: 1.817
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.